{
  "report_rows": [
    {
      "kpi": "Adjusted diluted EPS",
      "prediction": "BEAT",
      "answer": "pred ~$1.97 vs. cons $1.94",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Revenue",
      "prediction": "BEAT",
      "answer": "pred ~$813M vs. cons $804M",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Organic constant-currency revenue growth",
      "prediction": "IN-LINE",
      "answer": "pred ~5.4% vs. cons 5.5%",
      "confidence": "LOW"
    }
  ],
  "guide_rows": [
    {
      "kpi": "FY26 revenue guidance midpoint",
      "prediction": "LOWER",
      "answer": "guide ~$3.215B vs. cons $3.220B (FY26)",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "FY26 adjusted EBITDA guidance midpoint",
      "prediction": "UNCHANGED",
      "answer": "guide ~$1.810B vs. cons $1.810B (FY26)",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "FY26 adjusted diluted EPS guidance midpoint",
      "prediction": "LOWER",
      "answer": "guide ~$7.60 vs. cons $7.64 (FY26)",
      "confidence": "MEDIUM"
    }
  ],
  "day1_residual_pct": -3.5,
  "day1_confidence": "MEDIUM",
  "day5_residual_pct": -5,
  "day5_path": "FOLLOW-THROUGH",
  "day5_rationale": "A modest ~$1.97 vs. $1.94 EPS beat and ~$813M vs. $804M revenue beat are unlikely to offset unchanged FY26 revenue of ~$3.215B versus ~$3.220B consensus and EPS of ~$7.60 versus ~$7.64 consensus; the resulting out-period estimate-reset risk should extend the initial negative residual move.",
  "day5_confidence": "MEDIUM"
}